DelveInsight Business Research, LLP: Chronic Kidney Disease Market to Observe Impressive Growth at a CAGR of 8.7% by 2032, Estimates DelveInsight : vimarsana.com
The expected launch of therapies by several pharma companies such as ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others